1. Minagawa M, Makuuchi M. treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombosis. World J Gastroenterol. 2006;12(47):7561–7.
2. Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y, et al. Hepatocellular carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting. J ClinOncol. 2010;28:3994–4005.
3. Hatano E, Uemoto S, Yamane H, Yamamoto M, Japanese society of hepato-biliary-pancreatic surgery. Significance of hepatic resection and adjuvant hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombus in the first branch of portal vein and the main portal trunk: a project study for hepatic surgery of the Japanese society of hepato-biliary-pancreatic surgery. J HepatobiliaryPancreatSci. 2018;25:395–402.
4. Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, et al. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatology. 2016;65:938–43.
5. Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, et al. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis. ClinMolHepatol. 2016;22:160–7.